SINGAPORE (July 15): Boustead Singapore last week released its FY20 results which were in line with expectations. With that, CGS-CIMB Research continues to rate Boustead “add” with an unchanged target price of $1.00.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply